Annals of Pediatric Cardiology
About us | Current Issue | Archives | Ahead of Print | Instructions | Submission | Subscribe | Advertise | Contact | Login 
  Instructions 
  Search 
  My preferences 

 


This article has been cited by
1Determination of the catalytic activity of LEOPARD syndrome-associated SHP2 mutants toward parafibromin, a bona fide SHP2 substrate involved in Wnt signaling
Saori Noda,Atsushi Takahashi,Takeru Hayashi,Sei-ichi Tanuma,Masanori Hatakeyama
Biochemical and Biophysical Research Communications.2016;469(4)1133
[DOI]
2Síndrome LEOPARD diagnosticado en un adulto
Rosario Alarcón-Cabrera,Felipe Partarrieu-Mejías,Nicolás Peña-Toro
Piel.2016;31(5)376
[DOI]
3Syndrome LEOPARD et carcinome épidermoïde labial : présentation d’un cas
Chérifa Faïza Tabeti-Bentahar,Fatma Bouzouina,Amina Nouria Tabeti-Hamza
Médecine Buccale Chirurgie Buccale.2012;18(3)215
[DOI]
4Pediatric patients with RASopathy-associated hypertrophic cardiomyopathy: the multifaceted consequences of PTPN11 mutations
Giulio Calcagni,Maria Cristina Digilio,Bruno Marino,Marco Tartaglia
Orphanet Journal of Rare Diseases.2019;14(1)215
[DOI]
5Heterozygous deletion of AKT1 rescues cardiac contractility, but not hypertrophy, in a mouse model of Noonan Syndrome with Multiple Lentigines
Rajika Roy,Maike Krenz
Journal of Molecular and Cellular Cardiology.2017;112(1)83
[DOI]
6Biventricular Hypertrophic Cardiomyopathy in a Child with LEOPARD Syndrome: a Case Report
Cristina Blesneac,Carmen-Corina ?uteu,Claudia Banescu,Theodora Benedek,Imre Benedek,Rodica Toganel
Journal of Interdisciplinary Medicine.2017;2(4)345
[DOI]
7Human Induced Pluripotent Stem-Cell-Derived Cardiomyocytes as Models for Genetic Cardiomyopathies
Andreas Brodehl,Hans Ebbinghaus,Marcus-André Deutsch,Jan Gummert,Anna Gärtner,Sandra Ratnavadivel,Hendrik Milting
International Journal of Molecular Sciences.2019;20(18)4381
[DOI]